文献速递神经MR

多序列MRI影像组学模型鉴别胶质瘤复发与假性进展

Multi-Sequence MRI radiomics model for discrimination of recurrence and pseudoprogression in gliomas.
PubMed 文献 · Eur J Radiol · 2025-11-06

回顾性分析240例弥漫性胶质瘤(本中心112例与UPENN数据集59例用于训练,独立测试队列69例)的T1WI、T2WI、T1CE、FLAIR、DWI(b=1000)及ADC图影像组学特征,经特征工程保留45个特征并比较十种机器学习模型,多层感知器(MLP)表现较高(AUC 0.88±0.05,准确率0.81±0.04),支持向量机(SVM)AUC为0.779。

要点

  • 多序列MRI影像组学模型可鉴别胶质瘤复发与假性进展,MLP模型AUC达0.88±0.05。
  • MLP模型对数据扰动稳健,AUC的相对标准差(RSDAUC)为5.25%。
  • SVM模型预测性能良好,AUC为0.779。

核心结论

  • 影像模型能有效鉴别胶质瘤复发与假性进展,作者认为值得在临床实践中使用。

研究设计与样本

  • 回顾性分析240例弥漫性胶质瘤MRI数据,其中本中心112例与UPENN数据集59例用于训练,独立测试队列69例;提取T1WI、T2WI、T1CE、FLAIR、DWI(b=1000)及ADC图的影像组学特征,经特征工程和机器学习建模。

诊断标准与关键数值

  • 经六序列组合特征工程后保留45个特征;SVM模型AUC为0.779;MLP模型AUC为0.88±0.05、准确率0.81±0.04、RSDAUC为5.25%。

临床应用与阅片要点

  • 作者认为影像模型可有效鉴别胶质瘤复发与假性进展,值得在临床实践中使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECT: The clinical treatment strategies for glioma recurrence and pseudoprogression are completely different. Precise differentiation between these conditions is essential and radiomics serves as a mature solution to bridge this gap.

METHODS: We retrospectively analyzed MRI data from 240 diffuse glioma -- 112 from our Center1 and 59 from the UPENN dataset for training, plus an independent test cohort of 69. Radiomics features from T1WI, T2WI, T1CE, FLAIR, DWI(b = 1000), and ADC maps were extracted and used in feature engineering and machine learning to differentiate glioma from pseudoprogression. In the training set, the prediction performance was evaluated by using accuracy and the area under the curve (AUC) of the receiver operating characteristics, while the model stability was analyzed by using the relative standard deviation of the AUC (RSDAUC).

RESULTS: We extracted features by combining six sequences, and after feature engineering, 45 features remained. We then applied these features to ten machine learning models and finally validated them in a separate training set. Support Vector Machine (SVM) achieved favorable prediction performance (AUC: 0.779) whereas Multilayer Perceptron (MLP) displayed high performance (AUC: 0.88 ± 0.05, accuracy: 0.81 ± 0.04) and high robustness against data perturbation (RSDAUC: 5.25 %) CONCLUSIONS: Imaging models effectively differentiate between glioma recurrence and pseudoprogression, warranting their utilization in clinical practice.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Li J, Xu Q, Fan X, et al. Multi-Sequence MRI radiomics model for discrimination of recurrence and pseudoprogression in gliomas. Eur J Radiol. 2025. PMID: 41237487. doi:10.1016/j.ejrad.2025.112508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。